FIELD: medicine; pharmacology.
SUBSTANCE: agent includes cartilage or chondroitin sulfate and alible zinc.
EFFECT: depression of by-effects and improvement of an absorption of iron at peroral introduction.
28 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS SUITABLE TO TREAT DERMAL SIGNS OF AGING | 2005 |
|
RU2409290C2 |
| SYNERGISTIC COMPOSITION OF VEGETABLE ORIGIN (VARIANTS), METHOD FOR TREATMENT OF DISEASES WITH ITS USING | 2005 |
|
RU2319494C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
| COSMETIC COMPOSITION | 2012 |
|
RU2613121C2 |
| SYGETHIN-BASED PHARMACEUTICAL STRUCTURE FOR OSTEOPOROSIS PREVENTION AND TREATMENT (VERSIONS) | 2007 |
|
RU2356546C1 |
| METHOD OF OBTAINING HIGHLY PURIFIED ASIATICOSIDE COMPOSITION FROM Centella asiatica AND METHOD OF APPLICATION THEREOF | 2010 |
|
RU2565410C2 |
| PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2448689C2 |
| COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT | 2011 |
|
RU2566050C2 |
| COMPOSITION FOR TOPICAL APPLICATION CONTAINING GLYCERIN AND YEAST EXTRACT | 2019 |
|
RU2801139C2 |
| LOCAL AND EXTERNAL SYGETHIN-BASED PHARMACEUTICAL COMPOSITION FOR MENOPAUSAL DISORDERS PREVENTION AND TREATMENT | 2007 |
|
RU2356548C1 |
